It improves the muscular efficiency of sport horses
Research into BPC-157's role in gut healing and KPV's cytokine suppression suggests they may be used together in supervised clinical protocols addressing both the inflammatory driver and the tissue consequence, though no standardized combination protocol currently exists
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
Chemical structure of Acetyl-L-Carnitine: There isnt a huge amount of information about the mechanism by which ALC could potentially affect these different diseases, although there are studies that show that ALC upregulates various transporter proteins and transcription factors that could play a part in how it is working
Moreover, with decreasing cereulide productivity higher amounts of tetradepsipeptide esters were liberated when compared to the octa- and dodecadepsipeptide esters (Fig
